DK3429689T3 - Acellulære placentapræparater - Google Patents
Acellulære placentapræparater Download PDFInfo
- Publication number
- DK3429689T3 DK3429689T3 DK17767314.2T DK17767314T DK3429689T3 DK 3429689 T3 DK3429689 T3 DK 3429689T3 DK 17767314 T DK17767314 T DK 17767314T DK 3429689 T3 DK3429689 T3 DK 3429689T3
- Authority
- DK
- Denmark
- Prior art keywords
- placental preparations
- acellular
- acellular placental
- preparations
- placental
- Prior art date
Links
- 230000003169 placental effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307629P | 2016-03-14 | 2016-03-14 | |
| PCT/US2017/022257 WO2017160804A1 (en) | 2016-03-14 | 2017-03-14 | Acellular placental preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3429689T3 true DK3429689T3 (da) | 2022-01-31 |
Family
ID=59851853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17767314.2T DK3429689T3 (da) | 2016-03-14 | 2017-03-14 | Acellulære placentapræparater |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12157899B2 (da) |
| EP (2) | EP4008400B1 (da) |
| JP (2) | JP7050692B2 (da) |
| CN (2) | CN114404454A (da) |
| AU (2) | AU2017235220B2 (da) |
| CA (1) | CA3016606A1 (da) |
| DK (1) | DK3429689T3 (da) |
| ES (1) | ES2907751T3 (da) |
| PL (1) | PL3429689T3 (da) |
| WO (1) | WO2017160804A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4008400B1 (en) | 2016-03-14 | 2025-06-18 | Plakous Therapeutics, Inc. | Acellular placental preparations |
| WO2018144694A1 (en) | 2017-02-01 | 2018-08-09 | Plakous Therapeutics, Inc. | Placental tissue compositions |
| US20220195382A1 (en) * | 2019-04-04 | 2022-06-23 | THT Biomaterials GmbH | A novel human-material-based platfom technology for tissue engineering |
| KR20220033465A (ko) | 2019-05-06 | 2022-03-16 | 액셀러레이티드 바이오사이언시스 코포레이션 | 전구 조절성 세포영양막 세포 및 그의 용도 |
| CN114980909A (zh) * | 2019-11-27 | 2022-08-30 | 无痛疗法股份有限公司 | 用于坏死性小肠结肠炎的无细胞胎盘治疗 |
| US20240002788A1 (en) * | 2020-12-03 | 2024-01-04 | VityleBio, Inc. | Regenerative Tissue Extract from Non-Human Mammalian Placenta |
| CA3230944A1 (en) * | 2021-09-07 | 2023-03-16 | Scott A. Washburn | Acellular placental therapies |
| CN114886925B (zh) * | 2022-05-25 | 2023-10-13 | 兰州大学 | 羊胎盘提取物在制备预防或治疗癌症恶病质药物中的应用 |
| CN116370690B (zh) * | 2023-03-10 | 2024-08-20 | 广州正源生物技术有限公司 | 胎盘底蜕膜复合制剂、其制法，含有其的医用敷料及应用 |
| US20250051723A1 (en) * | 2023-08-08 | 2025-02-13 | Mimedx Group, Inc. | Pourable placental collagen matrix sheet |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030235580A1 (en) | 2002-06-24 | 2003-12-25 | Fen Zhang | Amniotic membrane mediated delivery of bioactive molecules |
| US8187639B2 (en) * | 2005-09-27 | 2012-05-29 | Tissue Tech, Inc. | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment |
| WO2007038686A2 (en) | 2005-09-27 | 2007-04-05 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
| US8071135B2 (en) * | 2006-10-04 | 2011-12-06 | Anthrogenesis Corporation | Placental tissue compositions |
| KR101118017B1 (ko) | 2009-09-04 | 2012-02-24 | (주)차바이오앤디오스텍 | 태반 추출물을 제조하는 방법 및 태반 추출물 |
| EP3351624B1 (en) * | 2010-02-18 | 2022-09-14 | Osiris Therapeutics, Inc. | Methods of manufacture of therapeutic products comprising vitalized placental dispersions |
| CN102327640A (zh) | 2011-09-29 | 2012-01-25 | 协和干细胞基因工程有限公司 | 一种脱细胞羊膜的制备方法 |
| US20130218274A1 (en) | 2011-12-02 | 2013-08-22 | Mimedx Group, Inc. | Shredded tissue grafts and methods for making and using the same |
| US10576037B2 (en) | 2012-03-14 | 2020-03-03 | MAM Holdings of West Florida, L.L.C. | Compositions comprising placental collagen for use in wound healing |
| US20140248328A1 (en) | 2012-08-31 | 2014-09-04 | Jennifer L. Wehmeyer | Methods of treating amniotic membranes using supercritical fluids and compositions and apparatuses prepared therefrom |
| CN103114073B (zh) | 2013-01-23 | 2014-11-05 | 宁波大学 | 一种人羊膜的脱细胞方法 |
| EP3043771A4 (en) | 2013-09-10 | 2017-05-03 | MIMEDX Group Inc. | Cosmetic uses of molded placental compositions |
| CN103520780B (zh) | 2013-10-24 | 2015-03-25 | 陕西瑞盛生物科技有限公司 | 一种生物羊膜及其制备方法 |
| CN103861151B (zh) | 2014-03-27 | 2016-03-30 | 成都青山利康药业有限公司 | 一种脱细胞胎盘基质材料的制备方法 |
| AU2014393402A1 (en) * | 2014-05-07 | 2016-11-24 | Osiris Therapeutics, Inc. | Therapeutic placental compositions, methods of making and methods of use |
| EP3297645A4 (en) * | 2015-05-20 | 2018-12-12 | Tissuetech, Inc. | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
| EP4008400B1 (en) | 2016-03-14 | 2025-06-18 | Plakous Therapeutics, Inc. | Acellular placental preparations |
| WO2018144694A1 (en) | 2017-02-01 | 2018-08-09 | Plakous Therapeutics, Inc. | Placental tissue compositions |
-
2017
- 2017-03-14 EP EP21198147.7A patent/EP4008400B1/en active Active
- 2017-03-14 EP EP17767314.2A patent/EP3429689B1/en active Active
- 2017-03-14 PL PL17767314T patent/PL3429689T3/pl unknown
- 2017-03-14 DK DK17767314.2T patent/DK3429689T3/da active
- 2017-03-14 WO PCT/US2017/022257 patent/WO2017160804A1/en not_active Ceased
- 2017-03-14 JP JP2018549193A patent/JP7050692B2/ja active Active
- 2017-03-14 AU AU2017235220A patent/AU2017235220B2/en active Active
- 2017-03-14 CA CA3016606A patent/CA3016606A1/en active Pending
- 2017-03-14 US US16/321,075 patent/US12157899B2/en active Active
- 2017-03-14 CN CN202210069029.XA patent/CN114404454A/zh active Pending
- 2017-03-14 CN CN201780023893.3A patent/CN109069867B/zh active Active
- 2017-03-14 ES ES17767314T patent/ES2907751T3/es active Active
-
2022
- 2022-03-29 JP JP2022052707A patent/JP2022101565A/ja active Pending
- 2022-06-10 AU AU2022204044A patent/AU2022204044B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL3429689T3 (pl) | 2022-03-21 |
| CA3016606A1 (en) | 2017-09-21 |
| WO2017160804A1 (en) | 2017-09-21 |
| EP3429689A1 (en) | 2019-01-23 |
| US12157899B2 (en) | 2024-12-03 |
| AU2022204044B2 (en) | 2024-03-07 |
| EP3429689A4 (en) | 2019-11-06 |
| AU2022204044A1 (en) | 2022-06-30 |
| EP3429689B1 (en) | 2021-12-22 |
| CN109069867A (zh) | 2018-12-21 |
| EP4008400C0 (en) | 2025-06-18 |
| CN114404454A (zh) | 2022-04-29 |
| CN109069867B (zh) | 2022-02-01 |
| JP7050692B2 (ja) | 2022-04-08 |
| JP2022101565A (ja) | 2022-07-06 |
| ES2907751T3 (es) | 2022-04-26 |
| US20200239836A1 (en) | 2020-07-30 |
| AU2017235220A1 (en) | 2018-09-27 |
| EP4008400B1 (en) | 2025-06-18 |
| AU2017235220B2 (en) | 2022-03-24 |
| JP2019508478A (ja) | 2019-03-28 |
| EP4008400A1 (en) | 2022-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291932B2 (en) | Nanoparticle compositions for sustained therapy | |
| IL282304A (en) | Topical pharmaceutical compositions | |
| IL268684A (en) | Compositions and methods for immunooncology | |
| EP3551285A4 (en) | DEFIBRILLATOR | |
| HRP20180501T1 (hr) | Pripravci koje sadrže bakterijske sojeve | |
| HUE053101T2 (hu) | Javított T-sejt-készítmények | |
| IL263846B (en) | Formulation of a peptide vaccine | |
| HUE041969T2 (hu) | Baktériumtörzseket tartalmazó készítmények | |
| DK3287154T3 (da) | Ventrikulær hjælpeindretning | |
| HUE058288T2 (hu) | Pridopidin módosított hatóanyag-leadású készítményei | |
| HUE046221T2 (hu) | Bakteriális törzseket tartalmazó készítmények | |
| HUE058252T2 (hu) | Baktériumtörzseket tartalmazó készítmények | |
| HUE046681T2 (hu) | Baktériumtörzseket tartalmazó készítmények | |
| DK3429689T3 (da) | Acellulære placentapræparater | |
| HUE053347T2 (hu) | Glikopeptid-készítmények | |
| EP3472305A4 (en) | GENETICALLY MODIFIED TREG CELLS | |
| EP3536308A4 (en) | COSMETIC PRODUCT FOR THE SKIN | |
| HUE054096T2 (hu) | Krémesítõ készítmény | |
| IL263714A (en) | Depot formulations | |
| HUE053624T2 (hu) | Ciklosporint tartalmazó készítmények | |
| DK3481887T3 (da) | Tilberedninger som hydrofoberingsmidler | |
| EP3476198A4 (en) | HARVESTER | |
| EP3531936A4 (en) | REMOVABLE PLIERS | |
| EP3498837A4 (en) | Genome editing method | |
| PL3709970T3 (pl) | Preparaty linezolidu |